Three Rivers Collaborates with Concordia University for Medical Research
TORONTO, ON, July 18, 2016 - The Natural Sciences and Engineering Research Council of Canada (NSERC) grants Three Rivers Cardiovascular Systems a research partnership with Dr. Lyes Kadem, Associate Professor in the Department of Mechanical and Industrial Engineering at Concordia University.
Dr. Kadem, leading the Laboratory of Cardiovascular Fluid Dynamics at Concordia University, with his laboratory team have developed a unique cardiac simulator and advanced techniques for analyzing complex cardiovascular fluid flows. This collaboration will be focusing on developing our next generations of multi-sensor medical devices for interventional cardiologists.
“These research efforts will foster a synergy between Concordia university and Three Rivers. The company will significantly benefit from the scientific and technical expertise of our research team, ” says Dr. Kadem.
The partnership was enabled through NSERC Engage Grant, a collaborative research and development grant designed to give innovative companies that operate from a Canadian base access to university and college researchers with an industrial partner. Through a short-term project, researchers combine their expertise and capabilities to address the specific company’s challenge.
“This collaboration will allow our company to have access to expertise and resources in cardiovascular fluid dynamics to optimize and demonstrate our next sensor technology,” says Eric Caron, CEO of Three Rivers.
The collaboration project is aimed at solving the company-specific problem through the generation of new knowledge and the application of existing knowledge in an innovative manner. Any intellectual property (IP) arising from the project will belong to Three Rivers.
About Three Rivers:
The company was founded in 2013 to develop and commercialize multi-sensor medical devices for interventional cardiologists. Three Rivers’ innovative medical devices provide real-time critical data for heart diagnosis and therapy to improve patient outcomes while reducing healthcare costs with heart diseases.